Glasgow RE, Vogt TM, Boles SM
To be clear, GLP-1s are not FDA-approved for treating these conditions right now, but if more research proves they are safe and effective, they could receive formal approval for these uses (or others) in the future
Dont mix it with other shots, like insulin, in the same syringe
It activates: GLP-1 , just like semaglutide GIP (glucose-dependent insulinotropic polypeptide) , a second hormone involved in appetite, insulin regulation, and fullness Because tirzepatide acts on two hormonal pathways, many patients experience: Stronger appetite control More stable blood sugar Greater total weight loss Better control over cravings Think of tirzepatide as a double-pathway medication that supports weight loss from multiple angles
GI side effects may temporarily increase during the transition because tirzepatide adds GIP receptor activation
Tirzepatides: Mounjaro: Diabetes Zepbound: Chronic weight management in adults (18 and over) and patients with OSA and obesity or overweight In the next few years, it appears new and improved drugs may be available